| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUCCGGGUGACGUCUCCCGAGGGCGUCGGCAGGGUCGGCGGCGUCGGCA… | 971 nt | 0.5108 | |
| GACGUCUCCCGAGGGCGUCGGCAGGGUCGGCGGCGUCGGCAGCAGUGUC… | 1012 nt | 0.5168 | |
| GACGUCUCCCGAGGGCGUCGGCAGGGUCGGCGGCGUCGGCAGCAGUGUC… | 945 nt | 0.5206 |
This gene belongs to the splicing factor SR family of genes. U2 auxiliary factor, comprising a large and a small subunit, is a non-snRNP protein required for the binding of U2 snRNP to the pre-mRNA branch site. This gene encodes the small subunit which plays a critical role in both constitutive and enhancer-dependent RNA splicing by directly mediating interactions between the large subunit and proteins bound to the enhancers. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008] CIViC Summary for U2AF1 Gene U2AF1 is one of several spliceosome complex genes frequently mutated in a variety of hematologic malignancies, particularly de novo myelodysplastic syndromes (MDS), as well as solid tumors such as lung and pancreatic cancers. Two hotspot mutations (S34 and Q157) occur within the two zinc-finger domains of the U2AF1 protein. These mutations have been associated with altered splicing patterns in vitro and in vivo. U2AF1 mutations in MDS have been associated with an increased risk of transformation to secondary acute myeloid leukemia, however, the impact of these mutations on overall survival has been an area of debate.
No relevant information is available at the moment.